Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia.

Literature DB >> 19434514

Erythropoietin augments the efficacy of therapeutic angiogenesis induced by allogenic bone marrow stromal cells in a rat model of limb ischemia.

Xiangqian Hou¹, Xuejun Wu, Junxi Ma, Xinhui Lv, Xing Jin.

Abstract

Transplantation of adult marrow stromal cells (MSCs) has been developed as a new method of treating severe ischemia diseases by therapeutic angiogenesis. Erythropoietin (EPO) is capable of inducing angiogenesis and inhibiting MSCs apoptosis. The effect of EPO on the therapeutic potency of MSCs transplantation in a rat model of limb ischemia was investigated in the current study. The results indicate that the combined treatment with MSC transplantation and EPO infusion is superior to MSC transplantation alone in the treatment of limb ischemia. MSCs transplantation and EPO infusion could enhance the angiogenic effect of each other to achieve a better therapeutic effect. This combination therapy may become a more effective approach for ischemia diseases of the limbs.

Entities: Disease Gene Species

Mesh：

Substances：
Erythropoietin

Year: 2009 PMID： 19434514 DOI： 10.1007/s11033-009-9541-3

Source DB: PubMed Journal: Mol Biol Rep ISSN： 0301-4851 Impact factor: 2.316

37 in total

Review 1. Therapeutic angiogenesis: another passing phase?

Authors: Gregg L Semenza
Journal: Circ Res Date: 2006-05-12 Impact factor: 17.367

2. Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis.

Authors: Koichi Kobayashi; Takahisa Kondo; Natsuo Inoue; Mika Aoki; Masaaki Mizuno; Kimihiro Komori; Jun Yoshida; Toyoaki Murohara
Journal: Arterioscler Thromb Vasc Biol Date: 2006-04-27 Impact factor: 8.311

Review 3. Stem cell technology and bioceramics: from cell to gene engineering.

Authors: H Ohgushi; A I Caplan
Journal: J Biomed Mater Res Date: 1999

4. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

Authors: Christopher Heeschen; Alexandra Aicher; Ralf Lehmann; Stephan Fichtlscherer; Mariuca Vasa; Carmen Urbich; Christiane Mildner-Rihm; Hans Martin; Andreas M Zeiher; Stefanie Dimmeler
Journal: Blood Date: 2003-04-17 Impact factor: 22.113

5. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation.

Authors: Takuya Ozawa; Ken Toba; Kiminori Kato; Shiro Minagawa; Takashi Saigawa; Haruo Hanawa; Yashiro Makiyama; Masato Moriyama; Kei-Ichiro Honma; Manabu Isoda; Go Hasegawa; Makoto Naito; Masuhiro Takahashi; Yoshifusa Aizawa
Journal: J Mol Cell Cardiol Date: 2006-05 Impact factor: 5.000

6. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model.

Authors: T Kobayashi; K Hamano; T S Li; T Katoh; S Kobayashi; M Matsuzaki; K Esato
Journal: J Surg Res Date: 2000-04 Impact factor: 2.192

7. Isolation of putative progenitor endothelial cells for angiogenesis.

Authors: T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal: Science Date: 1997-02-14 Impact factor: 47.728

8. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model.

Authors: Abdulaziz Al-Khaldi; Hilal Al-Sabti; Jacques Galipeau; Kevin Lachapelle
Journal: Ann Thorac Surg Date: 2003-01 Impact factor: 4.330

9. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

Authors: Donna M Mancini; Stuart D Katz; Chim C Lang; John LaManca; Alhakam Hudaihed; Ana-Silvia Androne
Journal: Circulation Date: 2003-01-21 Impact factor: 29.690

10. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain.

Authors: Ihsan Solaroglu; Ayse Solaroglu; Erkan Kaptanoglu; Suat Dede; Ali Haberal; Etem Beskonakli; Kamer Kilinc
Journal: Childs Nerv Syst Date: 2002-12-14 Impact factor: 1.475

13 in total

1. The protective effects and potential mechanism of Calpain inhibitor Calpeptin against focal cerebral ischemia-reperfusion injury in rats.

Authors: Sheng Peng; Zhongshen Kuang; Yan Zhang; Hang Xu; Qinghong Cheng
Journal: Mol Biol Rep Date: 2010-05-16 Impact factor: 2.316

2. Recombinant expression of human nerve growth factor beta in rabbit bone marrow mesenchymal stem cells.

Authors: Bo-Sheng Fan; Ji-Yu Lou
Journal: Mol Biol Rep Date: 2010-03-17 Impact factor: 2.316

Review 3. Mesenchymal stromal cells to halt the progression of type 1 diabetes?

Authors: Per-Ola Carlsson; Olle Korsgren; Katarina Le Blanc
Journal: Curr Diab Rep Date: 2015-07 Impact factor: 4.810

Review 4. Death and inflammation following somatic cell transplantation.

Authors: Ian B Copland; Jacques Galipeau
Journal: Semin Immunopathol Date: 2011-05-01 Impact factor: 9.623

5. Discovery of a pyrazole derivative promoting angiogenesis through modulating reactive oxygen species and interferon-inducible protein 10 levels.

Authors: Maohua Wang; Jingyong Zhang; Xuejun Wu; Xing Jin; Baoxiang Zhao; Lu Zhang; Hai Yuan; Hua Zhou; Binbin Gao; Wei Lv; Xiangqian Kong; Junying Miao
Journal: Mol Biol Rep Date: 2010-09-15 Impact factor: 2.316

6. The restoration of full-thickness cartilage defects with mesenchymal stem cells (MSCs) loaded and cross-linked bilayer collagen scaffolds on rabbit model.

Authors: Yiying Qi; Tengfei Zhao; Ke Xu; Tianyang Dai; Weiqi Yan
Journal: Mol Biol Rep Date: 2011-05-19 Impact factor: 2.316